Advertisement
Survey Series
For Advertisers
|
|
||||
|
Companies On the Fence About Biodefense
What will it take to make vaccines and drugs for smallpox, Ebola, and plague look like enticing business prospects?
The Scientist 2004, 18(20):56
|
||||
|
|
||||
|
Signed into law by President George W. Bush in July, Project BioShield allows the federal government to spend $5.6 billion over 10 years to purchase vaccines and drugs for smallpox, anthrax, botulinum toxin, Ebola virus, plague, and other pathogens and infections. While biotechnology and pharmaceutical companies praised the initiative at the time, most are still sitting on the sidelines, waiting for additional legislation that would make biodefense a more attractive business prospect.
|
|
|||||||||
|
|||||||||
|
